Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.41 |
| ▸ | FABP4 | P15090 | 3/20 | 0.44 |
| ▸ | FABP3 | P05413 | 2/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.42 |
| ▸ | NMT1 | P30419 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL1033043 | 0.96 | FABP4 (0.44) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL1021278 | 0.96 | FABP4 (0.44) | FABP4FABP3FABP5GABRA1GABRB2 | |
| Potassium Ion SCHEMBL1022542 | 0.96 | FABP4 (0.44) | FABP4FABP3FABP5GABRA1GABRB2 | |
| Sulfurous Acid SCHEMBL30356309 | 0.82 | FABP4 (0.44) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL345363 | 0.77 | FABP4 (0.50) | FABP4FABP3FABP5GABRA1GABRB2 | |
| Calcium SCHEMBL29853758 | 0.75 | FABP4 (0.48) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL1033044 | 0.75 | FABP4 (0.48) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL1022543 | 0.75 | FABP4 (0.48) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL1021280 | 0.75 | FABP4 (0.48) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL346544 | 0.75 | FABP4 (0.48) | FABP4FABP3FABP5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2226060-B1 | CEMENT FOR DENTAL APPLICATIONS | KURARAY NORITAKE DENTAL INC (JP) | 2020-03-04 | — | — | EP | claimed |
| EP-2409997-B1 | REDOX-CURING TYPE COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2016-11-16 | — | — | EP | claimed |
| US-8552088-B2 | Cement for dental applications | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-08 | — | — | US | claimed |
| US-8545225-B2 | Redox-curing type composition | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-01 | — | — | US | claimed |
| EP-2409997-A1 | REDOX-CURING TYPE COMPOSITION | Kuraray Medical Inc. (JP) | 2012-01-25 | — | — | EP | claimed |
| US-20120016094-A1 | REDOX-CURING TYPE COMPOSITION | KURARAY MEDICAL INC. (JP) | 2012-01-19 | — | — | US | claimed |
| US-20100267856-A1 | CEMENT FOR DENTAL APPLICATIONS | KURARAY MEDICAL INC. (JP) | 2010-10-21 | — | — | US | claimed |
| EP-2226060-A1 | CEMENT FOR DENTAL APPLICATIONS | Kuraray Medical Inc. (JP) | 2010-09-08 | — | — | EP | claimed |
| CN-116635452-B | Free radically polymerizable crosslinking agent, curable composition, and adhesive therefrom | 3M INNOVATIVE PROPERTIES CO. (US) | 2026-05-26 | — | — | CN | disclosed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4717249-A1 | DENTAL COMPOSITION | Shofu Inc. (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-20260083644-A1 | METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE | SHOFU INC (JP) | 2026-03-26 | — | — | US | disclosed |
| US-20260083642-A1 | DENTAL COMPOSITION | SHOFU INC (JP) | 2026-03-26 | — | — | US | disclosed |
| US-20250381101-A1 | HIGHLY FLOWABLE DENTAL CURABLE COMPOSITION | SHOFU INC. (JP) | 2025-12-18 | — | — | US | disclosed |
| US-6387979-B1 | FOR TOOTH TISSUE | KURARAY CO., LTD. (JP) | 2002-05-14 | — | — | US | disclosed |
| EP-1057468-A1 | Adhesive composition and method for producing it | KURARAY CO., LTD. (JP) | 2000-12-06 | — | — | EP | disclosed |
| EP-1051961-A1 | Bonding compositions for dental use | KURARAY CO., LTD. (JP) | 2000-11-15 | — | — | EP | disclosed |
| US-5486544-A | AROMATIC SULFINATE POLYMERIZATION CATALYST | KURARAY CO., LTD. (JP) | 1996-01-23 | — | — | US | disclosed |
| EP-0408357-B1 | Polymerizable composition | KURARAY CO (JP) | 1994-06-01 | — | — | EP | disclosed |
| EP-0408357-A2 | Polymerizable composition | KURARAY CO., LTD. (JP) | 1991-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083644-A1 | METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE | ARCN1, LBR, POLL | GABRA1 2670/4885GABRB2 2862/4885FABP4 4146/4885 |
| US-20250381101-A1 | HIGHLY FLOWABLE DENTAL CURABLE COMPOSITION | RCC1, H1-0, H1-3 | GABRA1 3737/4885GABRB2 4652/4885FABP4 4221/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | GABRA1 4487/4885GABRB2 4777/4885FABP4 4707/4885 |
| US-20260083642-A1 | DENTAL COMPOSITION | TAS2R42, COL2A1, TAS2R1 | GABRA1 3881/4885GABRB2 4494/4885FABP4 2043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.